Table 1.

Characteristics of persons who received one or more doses of HPV vaccine, 2008 - 2014

		Public funding	Private funding	Mixed funding	Total persons vaccinated N (%)a
Total [N, (%a)]		141,877 (83.8)	26,823 (15.8)	559 (0.3)	169,259
School year	2008/09	13,420	4,101	79	17,600 (10.4)
	2009/10	25,693	4,554	708	30,355 (17.9)
	2010/11	28,231	3,796	90	32,117 (19.0)
	2011/12	28,971	3,787	79	32,837 (19.4)
	2012/13	21,326	4,487	93	25,906 (15.3)
	2013/14	24,236	6,098	110	30,444 (18.0)
Age in years	9	397	10	11	408 (0.2)
	10b	50,787	43	16	50,846 (30.0)
	11b	30,670	67	10	30,747 (18.2)
	12	2,734	121	15	2,870 (1.7)
	13	1,730	200	18	1,948 (1.2)
	14c	30,615	364	108	31,087 (18.4)
	15c	19,504	954	91	20,549 (12.1)
	16	1,686	1,608	52	3,346 (2.0)
	17	1,200	2,151	54	3,405 (2.0)
	18	740	2,259	43	3,042 (1.8)
	19	294	1,953	31	2,278 (1.3)
	20	229	1,905	25	2,159 (1.3)
	21 to 26	1,150	9,301	76	10,527 (6.2)
	27 to 45	135	5,474	19	5,628 (3.3)
	>45	4	413	0	417 (0.3)
Gender	Female	141,661	24,180	545	166,386 (98.3)
	Male	216	2,643	14	2,873 (1.7)
Doses received	One dose	4,206	7,715	0	11,921 (7.0)
	Two doses	9,599	6,316	47	15,962 (9.4)
	Three doses	128,072	12,792	512	141,376 (83.5)
Rural/Urban Residence	Rural	29,446	3,804	163	33,413 (19.8)
	Urban	112,431	23,019	396	135,846 (80.3)
Income quintile	Q1	27,716	3,556	100	31,372 (18.5)
	Q2	28,184	4,664	106	32,954 (19.5)
	Q3	25,515	5,089	91	30,695 (18.1)
	Q4	30,991	6,591	140	37,722 (22.3)
	Q5	29,471	6,923	122	36,516 (21.6)
Type of HPV vaccine	qHPV	141,851	25,141	536	167,528 (99.0)
	bHPV	11	1,682	23	1,716 (1.0)
	U/Kd	15	0	0	15 (0)

^aSome percentages may not add to 100 due to rounding

^bMost children aged 10 or 11 years are grade 5 students

^cMost children aged 14 or 15 years are grade 9 students

^dU/K = unknown